Published in Int J Pharm on July 24, 2003
Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine. Int J Nanomedicine (2013) 0.81
An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccines. J Drug Deliv (2011) 0.80
The Use of Synthetic Carriers in Malaria Vaccine Design. Vaccines (Basel) (2015) 0.80
Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research. Biomed Res Int (2013) 0.78
Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies. Protein Cell (2015) 0.78
Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis. J Clin Microbiol (1991) 5.99
Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG. Infect Immun (1986) 3.80
Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum. J Exp Med (1984) 3.49
Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion. Proc Natl Acad Sci U S A (1984) 2.52
Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J Immunol (1987) 2.27
MPB59, a widely cross-reacting protein of Mycobacterium bovis BCG. Int Arch Allergy Appl Immunol (1986) 2.25
Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature (1987) 1.85
Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med (1979) 1.79
Multiprimer PCR system for differential identification of mycobacteria in clinical samples. J Clin Microbiol (1996) 1.68
Species-specific identification of Mycobacterium bovis by PCR. Microbiology (1995) 1.68
Isolation, characterization, and molecular cloning of a specific Mycobacterium tuberculosis antigen gene: identification of a species-specific sequence. Infect Immun (1991) 1.63
Regulation of the immune response in Plasmodium falciparum malaria. II. Antigen specific proliferative responses in vitro. Clin Exp Immunol (1983) 1.53
An analysis of in vitro T cell responsiveness in lepromatous leprosy. J Exp Med (1985) 1.52
Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion. Proc Natl Acad Sci U S A (1986) 1.51
Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro. J Immunol (1985) 1.46
Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions. Am J Trop Med Hyg (1992) 1.41
Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol Biochem Parasitol (1996) 1.39
Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation (1995) 1.36
Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors. Clin Exp Immunol (1984) 1.32
Temporal pattern in the effect of postnatal blood lead level on intellectual development of young children. Neurotoxicol Teratol (2001) 1.28
A species-specific nucleotide sequence of Mycobacterium tuberculosis encodes a protein that exhibits hemolytic activity when expressed in Escherichia coli. Infect Immun (1995) 1.21
Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature (1979) 1.15
Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci U S A (1995) 1.15
T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immun (2001) 1.11
Amplification of a 500-base-pair fragment from cultured isolates of Mycobacterium bovis. J Clin Microbiol (1999) 1.10
Regulation of the immune response in Plasmodium falciparum malaria. I. Non-specific proliferative responses in vitro and characterization of lymphocytes. Clin Exp Immunol (1983) 1.10
Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine (2002) 1.08
Immunodiagnosis of parasitic diseases with synthetic peptides. Curr Protein Pept Sci (2003) 1.05
Viral hepatitis in Colombia: a study of the "hepatitis of the Sierra Nevada de Santa Marta". Hepatology (1985) 1.05
Identification of B- and T-cell epitopes within the MTP40 protein of Mycobacterium tuberculosis and their correlation with the disease course. Infect Immun (1991) 1.05
Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles. Vaccine (2004) 1.02
CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Infect Immun (1999) 1.01
Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunol Lett (1995) 1.00
Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein. Vaccine (2000) 1.00
Identification of Mycobacterium bovis in bovine clinical samples by PCR species-specific primers. Can J Vet Res (1999) 0.99
Molecular analysis of HLA DR4-beta 1 gene in malaria vaccinees. Typing and subtyping by PCR technique and oligonucleotides. Parasite Immunol (1991) 0.98
Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells. Parasite Immunol (1996) 0.98
Immunization of cattle with synthetic peptides derived from the Boophilus microplus gut protein (Bm86). Vet Immunol Immunopathol (2002) 0.98
Leishmania: fine mapping of the Leishmanolysin molecule's conserved core domains involved in binding and internalization. Exp Parasitol (1999) 0.97
Regulation of the immune response in Plasmodium falciparum malaria: IV. T cell dependent production of immunoglobulin and anti-P. falciparum antibodies in vitro. Clin Exp Immunol (1987) 0.96
Characterization and localization of Plasmodium falciparum surface antigens on infected erythrocytes from west African patients. Blood (1991) 0.95
Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres. J Control Release (1998) 0.94
Regulation of hsp70 expression in Trypanosoma cruzi by temperature and growth phase. Mol Biochem Parasitol (1992) 0.94
Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates. Biomaterials (2002) 0.93
Plasmodium vivax: polymorphism in the merozoite surface protein 1 gene from wild Colombian isolates. Exp Parasitol (2000) 0.93
Biocompatibility evaluation of different alginates and alginate-based microcapsules. Biomacromolecules (2005) 0.93
Isolation and identification of mycobacteria in New World primates maintained in captivity. Vet Microbiol (2004) 0.93
Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC. Biomed Chromatogr (2005) 0.92
Organophosphorous pesticide exposure increases the frequency of sperm sex null aneuploidy. Environ Health Perspect (2001) 0.92
Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis. Immunol Lett (1995) 0.91
Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity. Vaccine (2001) 0.91
Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis. Clin Exp Immunol (1996) 0.91
Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum. Am J Trop Med Hyg (1990) 0.90
Functional and structural similarity of V gamma 9V delta 2 T cells in humans and Aotus monkeys, a primate infection model for Plasmodium falciparum malaria. J Immunol (2001) 0.90
Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis. Clin Exp Immunol (1999) 0.89
Geographical distribution of Plasmodium falciparum erythrocyte rosetting and frequency of rosetting antibodies in human sera. Am J Trop Med Hyg (1990) 0.89
During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins. Clin Exp Immunol (1995) 0.88
Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells. Int J Pharm (2008) 0.87
A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors. J Control Release (2008) 0.87
Immunogenic synthetic peptides against mycobacteria of potential immunodiagnostic and immunoprophylactic value. Lepr Rev (1986) 0.87
Plasmodium falciparum: red blood cell binding studies of peptides derived from histidine-rich KAHRP-I, HRP-II and HRP-III proteins. Acta Trop (2000) 0.87
Plasmodium falciparum EBA-175 kDa protein peptides which bind to human red blood cells. Parasitology (2000) 0.87
Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. Mol Ther (2005) 0.86
Quantum chemical analysis of MHC-peptide interactions for vaccine design. Mini Rev Med Chem (2010) 0.86
Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm (2008) 0.85
Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: evaluation of the sieving coefficient. Blood Purif (2006) 0.84
Sequence and diversity of MHC DQA and DQB genes of the owl monkey Aotus nancymaae. Immunogenetics (2000) 0.84
Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine (2001) 0.84
Comparative study of microcapsules elaborated with three polycations (PLL, PDL, PLO) for cell immobilization. J Microencapsul (2005) 0.84
Pre- and postnatal lead effect on head circumference: a case for critical periods. Neurotoxicol Teratol (1999) 0.84
Development and characterization of solid lipid nanoparticles loaded with magnetite. Int J Pharm (2002) 0.84
Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera. Clin Exp Immunol (2001) 0.84
Sequence and diversity of DRB genes of Aotus nancymaae, a primate model for human malaria parasites. Immunogenetics (2000) 0.83
Specific interactions of synthetic peptides derived from P. falciparum merozoite proteins with human red blood cells. Pept Res (1992) 0.83